MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 214 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q2 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,413,020 | +19.6% | 241,302 | +48.7% | 0.00% | – |
| Q2 2023 | $2,017,526 | -61.9% | 162,311 | -57.0% | 0.00% | -100.0% |
| Q1 2023 | $5,293,721 | -61.8% | 377,853 | -60.9% | 0.00% | -66.7% |
| Q4 2022 | $13,842,006 | +42.9% | 967,296 | +154.9% | 0.00% | +50.0% |
| Q3 2022 | $9,689,000 | +4.8% | 379,551 | +16.7% | 0.00% | 0.0% |
| Q2 2022 | $9,241,000 | -7.6% | 325,274 | +14.8% | 0.00% | 0.0% |
| Q1 2022 | $9,996,000 | -24.3% | 283,428 | -10.1% | 0.00% | -33.3% |
| Q4 2021 | $13,211,000 | +124.6% | 315,299 | +163.1% | 0.00% | +200.0% |
| Q3 2021 | $5,883,000 | +2.9% | 119,860 | -12.5% | 0.00% | 0.0% |
| Q2 2021 | $5,718,000 | +23.2% | 137,028 | +5.2% | 0.00% | 0.0% |
| Q1 2021 | $4,641,000 | +91.1% | 130,228 | +50.4% | 0.00% | 0.0% |
| Q4 2020 | $2,428,000 | – | 86,569 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |